Sofia, Bulgaria, January 11, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for December 2022 the Company recorded an increase in sales of 19% compared to the same month of the previous year, incl. 14% increase in domestic sales and 21% increase in export sales.

For 2022 the revenues from sales of products increase by 15%, incl. 10% increase of sales for the domestic market and 19% increase in export sales.